8 , 9 The progressive nature of T2D and thus, the requirement of treatment advancement to achieve and maintain glycaemic targets, has prompted the investigation of a higher dose of injectable semaglutide
Moreover, in addition to the direct action of GIP in adipose tissue to reduce serum triglyceride levels, GLP-1 may abolish the postprandial rise in triglyceride and free fatty acid concentrations by reducing intestinal absorption of dietary lipid, stemmed from the delayed gastric emptying (197, 198)
Once reconstituted, refrigerate and use within 20 days
Dosing protocols Phase 2 clinical trials used a titration schedule starting at 0.5mg weekly, escalating through 1mg, 2mg, 4mg, 8mg, and reaching maintenance doses of up to 12mg weekly over several months
Some researchers use oral semaglutide as a maintenance option after reaching their target weight on injectable formulations rather than as a direct replacement for high-dose tirzepatide
We asked the Anesthesia Manual App: Should GLP-1R agonists be stopped preoperatively?